PRRX1 and liver cancer: Intriguingly, the CCA marker KRT19 and the PROX1 targets PRRX1 and PPARG exhibited a negative correlation with PROX1 expression in tumor tissue (Fig. 7b), suggesting that PROX1 could regulate liver cancer plasticity and HCC versus CCA fate.